Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Aspen Chair Transition will see Ben Kruger replace Kuseni Dlamini as Aspen Pharmacare prepares for debt-free growth and new investment. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa’s local manufacturing goals. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
